Inspiratory Muscle Training and Behavioral Support to Alleviate Dyspnea and Promote Walking in Lung Cancer Survivors: A Pilot Study
Study Details
Study Description
Brief Summary
This is a pilot randomized study to investigate the feasibility, acceptability, safety, and effects of a novel tele-rehabilitation intervention for stage I-IIIA lung cancer survivors following curative intent therapy.
The specific aims and hypotheses are:
Specific Aim 1: Conduct a pilot, phase IIb, parallel randomized (1:1) study to investigate the feasibility, acceptability, and safety of inspiratory muscle training and behavioral support to promote walking in tele-rehabilitation with stage I-IIIA lung cancer survivors following curative intent therapy (N=40).
Hypothesis 1a: ≥ 20% eligible patients will enroll; ≥75% of participants will achieve ≥75% adherence to the tele-rehabilitation program.
Hypothesis 1b: ≥75% of participants will perceive tele-rehabilitation as acceptable (Telemedicine Satisfaction and Usefulness Questionnaire ≥4). There will be 0 intervention adverse events.
Specific Aim 2: Explore the effects of the tele-rehabilitation program (N=40).
Hypothesis 2: At 12 weeks, participants in the tele-rehabilitation (experimental) arm, compared to education only (control) arm, will have a trend of greater improvements in outcomes, including:
-
accelerometry-measured physical activity (primary outcome); and
-
functional capacity, self-reported physical activity, control of dyspnea and anxiety symptoms, sleep quality, and quality of life (secondary outcomes).
Condition or Disease | Intervention/Treatment | Phase |
---|---|---|
|
N/A |
Study Design
Arms and Interventions
Arm | Intervention/Treatment |
---|---|
Experimental: Tele-rehabilitation Participants in the tele-rehabilitation arm will receive a home-based, remotely delivered rehabilitation program. |
Behavioral: Tele-rehabilitation
The tele-rehabilitation intervention will include education, inspiratory muscle training, and behavioral support to promote walking.
|
Active Comparator: Education only Participants in the education arm will receive educational materials only, delivered through telecommunication messages. |
Other: Education only
The education only arm will receive information on the importance of general exercise following lung cancer treatment.
|
Outcome Measures
Primary Outcome Measures
- Difference in change in accelerometry-measured physical activity between baseline and week 12 [Baseline, mid study (week 6), and end of study (week 12).]
Physical activity will be measured by the activPAL4 device (PAL Technologies, Ltd).
Secondary Outcome Measures
- Difference in change in functional capacity between baseline and week 12 [Baseline, mid study (week 6), and end of study (week 12)]
Functional capacity will be measured using the mobile six-minute walk test.
- Difference in change in self-reported physical activity between baseline and week 12 [Baseline, mid study (week 6), and end of study (week 12)]
Self-reported physical activity will be measured using the International Physical Activity Questionnaire - Short Form
- Difference in change in control of dyspnea between baseline and week 12 [Baseline, mid study (week 6), and end of study (week 12)]
Dyspnea control will be measured using the the University of California, San Diego Shortness of Breath Questionnaire.
- Difference in change in anxiety symptoms between baseline and week 12 [Baseline, mid study (week 6), and end of study (week 12)]
Anxiety symptoms will be measured using the General Anxiety Disorder-7
- Difference in change in sleep quality between baseline and week 12 [Baseline, mid study (week 6), and end of study (week 12)]
Sleep quality will be measured using the Pittsburgh Sleep Quality Index
- Difference in change in quality of life between baseline and week 12 [Baseline, mid study (week 6), and end of study (week 12)]
Quality of life will be measured using the St. George's Respiratory Questionnaire
Eligibility Criteria
Criteria
Inclusion Criteria:
-
history of stage I-IIIA lung cancer;
-
completed curative intent therapy (i.e., lung cancer resection surgery, definitive radiation, or concurrent chemoradiation) within 1-6 months;
-
access to a mobile phone or personal computer with internet access;
-
willingness to wear activity trackers
Exclusion Criteria:
-
dementia (or cognitive impairment identified by chart review) resulting in inability to follow directions or provide written informed consent;
-
acute myocardial infarction, ventricular tachycardia, ventricular fibrillation, acute cerebrovascular event, or acute asthma exacerbation in past 2 months;
-
spontaneous pneumothorax in past 12 months;
-
Parkinson's disease;
-
multiple sclerosis;
-
amyotrophic lateral sclerosis;
-
additional movement/gait disorders that may be identified by chart review
Contacts and Locations
Locations
Site | City | State | Country | Postal Code | |
---|---|---|---|---|---|
1 | Kaiser Permanente Colorado | Aurora | Colorado | United States | 80014 |
Sponsors and Collaborators
- Kaiser Permanente
- American Lung Association
Investigators
None specified.Study Documents (Full-Text)
None provided.More Information
Publications
None provided.- LCD-820773